In addition, recent studies showed that CTGF inhibition ameliorates CG-induced peritoneal fibrosis through suppression of fibroblast accumulation, angiogenesis, and inflammation28,49. This evidence concerns the gene CCN2 and Peritoneal Fibrosis.